StockNews.com Initiates Coverage on Oragenics (NYSE:OGEN)
StockNews.com Initiates Coverage on Oragenics (NYSE:OGEN)
Analysts at StockNews.com began coverage on shares of Oragenics (NYSE:OGEN – Get Rating) in a research note issued on Tuesday. The brokerage set a "sell" rating on the stock.
StockNews.com的分析师开始报道以下股票 Oragenics（纽约证券交易所代码：OGEN — 获取评级） 在周二发布的研究报告中。该经纪公司对该股票设定了 “卖出” 评级。
Oragenics Price Performance
Oragenics 价格表现
NYSE OGEN opened at $3.05 on Tuesday. Oragenics has a 52 week low of $2.61 and a 52 week high of $24.00. The company has a market cap of $6.16 million, a P/E ratio of -0.39 and a beta of 0.37.
纽约证券交易所OGEN周二开盘价为3.05美元。Oragenics的52周低点为2.61美元，为52周的高点为24.00美元。该公司的市值为616万美元，市盈率为-0.39，beta值为0.37。
About Oragenics
关于 Oragenics
(Get Rating)
（获取评级）
Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health.
Oragenics Inc是一家生物技术公司，专注于开发和许可用于改善人类健康的创新产品和技术。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on Oragenics (OGEN)
- Medtronic: Reversal In-Play For This High-Yield Stock
- Is it 'Game Over' for Roblox After Reporting March Metrics Miss?
- Is it Time to Take Profits in Chip Stocks?
- Will Stratasys Continue to be a Runaway Bride?
- Garrett Motion Inc. Skids on Results: Is it Time to Buy the Dip?
- 免费获取 StockNews.com 关于 Oragenics (OGEN) 的研究报告
- 美敦力：这只高收益股票的反转正在进行中
- 在报告三月份的指标失误后，Roblox 的 “游戏结束了” 吗？
- 是时候在芯片股中获利了吗？
- Stratasys 会继续成为逃跑的新娘吗？
- Garrett Motion Inc. 对业绩持怀疑态度：是时候逢低买入了吗？
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Oragenics Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Oragenics及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。